Article info
Cardiac risk factors and prevention
Original research article
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in high vascular risk
- Correspondence to Dr Louis Potier, Department of Diabetology, Endocrinology and Nutrition, Bichat-Claude Bernard Hospital, 46 rue Henri Huchard, Paris 75018, France; louis.potier{at}gmail.com
Citation
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in high vascular risk
Publication history
- Received September 29, 2016
- Revised January 30, 2017
- Accepted February 3, 2017
- First published March 11, 2017.
Online issue publication
August 15, 2017
Article Versions
- Previous version (11 March 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.